NCT03874247View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury

PHASE3UnknownINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Acute Traumatic Injury
Interventions
DRUG

pelubiprofen 45mg

bid for 3 days after meal

DRUG

pelubiprofen placebo

bid for 3 days after meal

Trial Locations (1)

Unknown

RECRUITING

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT03874247 - Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury | Biotech Hunter | Biotech Hunter